Hyperons in a relativistic mean-field approach to asymmetric nuclear matter

Relativistic mean-field theory with $\delta$ meson, nonlinear isoscalar self-interactions and isoscalar-isovector cross interaction terms with parametrizations obtained to reproduce Dirac-Brueckner-Hartree-Fock calculations for nuclear matter is used to study asymmetric nuclear matter properties in $\beta$-equilibrium, including hyperon degrees of freedom and (hidden) strange mesons. Influence of cross interaction on composition of hyperon matter and electron chemical potential is examined. Softening of nuclear equation of state by the cross interactions results in lowering of hyperonization, although simultaneously enhancing a hyperon-induced decrease of the electron chemical potential, thus indicating further shift of a kaon condensate occurence to higher densities.Comment: 11 pages, 7 figures, 3 tables, published in Phys. Rev.

Study of e+,e− production in elementary and nuclear collisions near the production threshold with HADES

HADES is a second generation experiment designed to study dielectron production in proton, pion, and heavy ion induced reactions at the GSI accelerator facility in Darmstadt. The physics programme of HADES is focused on in-medium properties of the light vector mesons. In this contribution we present status of the HADES experiment, demonstrate its capability to identify rare dielectron signal, show first experimental results obtained from C+C reactions at 2 A GeV and shortly discuss physics programme of up-coming experimental runs. © 2004 Elsevier B.V. All rights reserved. 53 1 49 58 Cited By :1

Own the bone, a system-based intervention, improves osteoporosis care after fragility fractures

© 2016 By the Journal of Bone and Joint Surgery, Incorporated. Background: The goal of this study was to evaluate the effectiveness of the American Orthopaedic Association\u27s Own the Bone secondary fracture prevention program in the United States. Methods: The objective of this quality improvement cohort study was dissemination of Own the Bone and implementation of secondary prevention (osteoporosis pharmacologic and bone mineral density [BMD] test recommendations). The main outcome measures were the number of sites implementing Own the Bone and implementation of secondary prevention, i.e., orders for BMD testing and/or pharmacologic treatment. The 177 sites participating in the program were academic and community hospitals, orthopaedic surgery groups, and a health system; data were obtained from the first 125 sites utilizing its registry, between January 1, 2010, and March 31, 2015. It included all patients, aged 50 years or older, presenting with fragility fractures (n = 23,132) who were enrolled in the Own the Bone web-based registry. The interventions were education, development of program elements, dissemination, implementation, and evaluation of the Own the Bone program at participating sites. Results: A growing number of institutions implemented Own the Bone (14 sites in 2005-2006 to 177 sites in 2015). After consultation, 53% of patients had a BMD test ordered and/or pharmacologic therapy for osteoporosis